SlideShare a Scribd company logo
Dr. Jules Alla Kouadio (Médecins du Monde)
Training “Hepatitis C and HR for PWUD”,
20th
-24th
Sept. 2016, Nairobi, Kenya
Section 2: Natural
History of Hepatitis C
Learning objective of the session:
Describing HCV acute infection
Describing the different stages of liver
fibrosis
Outlining factors affecting
progress/accelerating of liver fibrosis
» Acute infection (within 6 months of initial infection)
– Most patients are asymptomatic
– Only 10% have symptomatic illness.
» Symptoms of acute infection usually appears
within 4 to 12 weeks of initial infection and may
persists for 2 to 12 weeks.
When a patient is recently infected
with hepatitis C virus
Symptoms of Acute Infection
» Hepatitis C causes serious problems in some patients
– Fibrosis
– Cirrhosis
– Advanced liver disease
– Hepatocellular carcinoma (liver cancer)
Why should you be concerned
about hepatitis C?
» The beginning of scarring
» Caused by infection, inflammation, or injury
» Can prevent the liver from working well
» Can lead to permanent scarring (cirrhosis)
Fibrosis
» Pronounced “sir-o-sis”
» Means “scarring of the liver”
» At risk for liver failure and liver cancer
» Requires close medical follow-up
Cirrhosis
Healthy Liver Liver with Cirrhosis
» Fatigue
» Difficulty thinking clearly or concentrating
» Yellow jaundice
» Swelling
» Fluid in the abdomen
» Gastrointestinal bleeding
» Poor blood clotting
Advanced Liver Disease
» Most common type of liver cancer
» Chronic hepatitis C increases the risk
» Treated with surgery, medications or liver transplant
Hepatocellular Carcinoma
Natural History of Hepatitis C
20 years progression rate accelerated with HIV, HBV,
Obesity, Diabetes, alcohol and cannabis
May also have Extra Hepatic manifestations
Natural History of Hepatitis C
Stage of Liver Fibrosis
Extra Hepatic Manifestations
Associated with HCV
11
NIH.NIH. NIH Consens State Sci StatementsNIH Consens State Sci Statements. 2002;19(3):1-46.. 2002;19(3):1-46.
22
Sene D et al.Sene D et al. Metab Brain DisMetab Brain Dis. 2004;19(3-4):357-381.. 2004;19(3-4):357-381.
HematologicHematologic
• Mixed cryoglobulinemiaMixed cryoglobulinemia11
• Aplastic anemiaAplastic anemia22
• ThrombocytopeniaThrombocytopenia22
• Non-Hodgkin's b-cell lymphomaNon-Hodgkin's b-cell lymphoma22
DermatologicDermatologic
• Porphyria cutanea tardaPorphyria cutanea tarda11
• Lichen planusLichen planus22
• Cutaneous necrotizingCutaneous necrotizing
• vasculitis2vasculitis2
RenalRenal
• GlomerulonephritisGlomerulonephritis11
• Nephrotic syndromeNephrotic syndrome22
EndocrineEndocrine
• HypothyroidismHypothyroidism22
• Diabetes mellitusDiabetes mellitus22
OcularOcular
• Corneal ulcerCorneal ulcer22
• UveitisUveitis22
VascularVascular
• Necrotizing vasculitisNecrotizing vasculitis22
• Polyarteritis nodosaPolyarteritis nodosa22
NeuromuscularNeuromuscular22
• Weakness/myalgiaWeakness/myalgia
• Peripheral neuropathyPeripheral neuropathy
• Arthritis/arthralgiaArthritis/arthralgia
Autoimmune PhenomenaAutoimmune Phenomena22
• CREST syndromeCREST syndrome
NeuropsychiatricNeuropsychiatric
• DepressionDepression11
» Alcohol consumption
– Alcohol significantly speeds up the rate of fibrosis
» Age and duration of infection
– People over 40 are progressively more susceptible to faster rates of
fibrosis.
» Gender
– Men are more likely to have faster progression to cirrhosis than women
» Co-infection with HIV and Hepatitis B
– HIV-HCV co-infection causes progression of liver damage
» Fatty liver
– Fat accumulates in the liver if it is unable to metabolize it properly due to
liver damage or excessive intake of fat through diet
» And other factors such as Drugs ,Metabolic syndrome,
Virological factors and coffee
Factors affecting disease
progression
1. Age/duration of infection
2. Co-infection with HIV also
accelerated the progress of
liver disease
– clearance of HCV is associated
with strong and persistent HCV-
specific cytotoxic T-lymphocyte
and CD4 lymphocyte responses
1. Co-infection with HBV
increase the risk of liver
fibrosis and HCC
Factors affecting disease progression
Alcohol consumption and chance of getting cirrhosis
Drinker Without Hepatitis C
Drinker With Hepatitis C
Hepatitis C Non-Drinker
Chance Of Getting
Cirrhosis
Non-Drinker
What is Excessive alcohol intake?
» A standard drink of
alcohol is defined
as 10 grams of
alcohol
» Excessive alcohol
intake defined as
>40 grams/day for
Women and >60
grams/day for Men
Alcohol intake recommended by WHO
» An Alcohol intake assessment is
recommended for all person with HCV
infection.
» Behaviour alcohol reduction intervention is
recommended for a person with moderate to
high alcohol intake.
Metabolic Syndrome
» Multiplex risk factors due to insulin
resistance together with abnormal adipose
deposition (Obesity+Diabetes)
» It is also a risk factor for coronary heart
disease and fatty liver
What can we advice if a patient has metabolic syndrome ?
» Life style modification
– Mainly diet and exercise
– To maintain the body weight within normal range
BMI >18.5 and <25
» Pharmacological therapy (for Hypertension,
Diabetes, hyperlipidaemia) if necessary
Marijuana (Bhang)
» Marijuana use is associated with accelerated
liver fibrosis due to a strong link between
heavy use of marijuana and steatosis.
» There is limited data available on the
correlation between Marijuana and Hep C.
Therefore, WHO has no recommendation on
Marijuana used in Hep C patient in April
2016 revised guideline.
How can identify Marijuana be used
» Assessment of drug use
» Suggest the patient to reduce the use of Marijuana as much
as possible
Herbs and over the counter drugs
» Chronic use of acetaminophen (paracetamol , Tylenol®
and
others) also increase the risk of liver damage.
» Ibuprofen and other anti-inflammatory medications
(Motrin®
, Advil®
, Aleve®
, and others)
» Herbal medicines are also widely used in Kenya and most
of the herbal medicines have no clear ingredients or effects.
» Iron supplements not recommended
– They may increase the rate of liver scarring
– Milk thistle is safe, BUT not shown to improve liver disease
Talk with your medical care provider before starting any new
medication or supplement
What kinds of advice should be given to the patients ?
» Not to take over-the-counter drugs
» Take medicines only when necessary under the
prescription of medical doctor
» To avoid using herbs or traditional medicines
» Need to be vaccinated against Hep B
Virological Factor
Some studies show that Genotype 3 is associated with
higher prevalence of steatosis which in turn accelerated
liver fibrosis.
Protection factor: Coffee
» Some studies show that regular taking of coffee (3
cups a day) may slow down the rate of progression of
liver disease in Hep C patients.
Exercice 1 : Quizz
» What % of HCV infected people develops chronic
HCV infection?
» What % of HCV infected people develops serious liver
disease?
» How long might this take?
» What factors might stop, slow down or increase the
risk of disease progression?
Exercise 2
1. HIV/HCV coinfection
2. HBV/HCV coinfection
3. Use 3 big cup of strong alcohol per day
4. Taking regularly paracetamol as pain killer
5. Smoking Marijuana
6. Being overweight
7. Being 55 years old
8. Injecting heroin with friends occasionally
1/ Print each elements below on a single papersheet, and distribute one sheet to every
participant
9. Getting tested for HCV
10. Being vaccinated againt HBV
11. Using my own equipment whenever using drugs
12. Taking methadone
13. Taking a lot of herbal treatment
14. HCV treatment
15. Reducing alcohol consumption
16. Good follow up on HIV treatment
2/ Identify in the room 3 corners:
1) factors accelerating liver disease
2) factors protective of liver disease
3) factors having no effect on liver disease
3/ Ask participants to stand in the corner corresponding
to the information on his· her papershette and explain to
the group his· her choice
This presentation was produced with the financial support of the French
development agency (AFD – Agence Franç aise de développement). The
ideas and opinions it contains are those of Médecins du Monde and do
not necessarily represent those of AFD.

More Related Content

What's hot

8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid final8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid final
antoine piaton
 
Revision of treatment protocols for hcv genotype 4 infection 2016
Revision of treatment protocols for hcv genotype 4 infection 2016Revision of treatment protocols for hcv genotype 4 infection 2016
Revision of treatment protocols for hcv genotype 4 infection 2016
Monkez M Yousif
 
5. hcv test counselling final
5. hcv test counselling final5. hcv test counselling final
5. hcv test counselling final
antoine piaton
 
HCV guidance may_24_2018b
HCV guidance may_24_2018bHCV guidance may_24_2018b
HCV guidance may_24_2018b
Dr. Afzal Haq Asif
 
Hepatitis C presentation by CADTH
Hepatitis C presentation by CADTHHepatitis C presentation by CADTH
Hepatitis C presentation by CADTH
PASaskatchewan
 
Revision of treatment protocols for hcv genotype 4 infection 2016
Revision of treatment protocols for hcv genotype 4 infection 2016Revision of treatment protocols for hcv genotype 4 infection 2016
Revision of treatment protocols for hcv genotype 4 infection 2016
Monkez M Yousif
 
02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy
UC San Diego AntiViral Research Center
 
March 192015talkforresidents final03232015 (1)
March 192015talkforresidents final03232015 (1)March 192015talkforresidents final03232015 (1)
March 192015talkforresidents final03232015 (1)
katejohnpunag
 
HIV-HCV Co-infection Slide Kit
HIV-HCV Co-infection Slide KitHIV-HCV Co-infection Slide Kit
HIV-HCV Co-infection Slide Kit
CIHR Canadian HIV Trials Network
 
HIV-HCV coinfection: still special in 2015?
HIV-HCV coinfection: still special in 2015?HIV-HCV coinfection: still special in 2015?
HIV-HCV coinfection: still special in 2015?
UC San Diego AntiViral Research Center
 
Who.hcv treatment guidelines 2016
Who.hcv treatment  guidelines 2016Who.hcv treatment  guidelines 2016
Who.hcv treatment guidelines 2016
Buruh harian lepas
 
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
UC San Diego AntiViral Research Center
 
HCV Story ---by Mohammed Hussien
HCV Story ---by Mohammed HussienHCV Story ---by Mohammed Hussien
HCV Story ---by Mohammed Hussien
Kafrelsheiekh University
 
HCV management, guidelines 2016
HCV management, guidelines 2016HCV management, guidelines 2016
HCV management, guidelines 2016
Usama Ragab
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
UC San Diego AntiViral Research Center
 
Antiretroviral Therapy Update 2014
Antiretroviral Therapy Update 2014Antiretroviral Therapy Update 2014
Antiretroviral Therapy Update 2014
Hivlife Info
 
Advances in hiv treatment
Advances in hiv treatmentAdvances in hiv treatment
Advances in hiv treatment
Chandan N
 
Best Practices in the Management of HCV/HIV Coinfection: Optimizing Treatment...
Best Practices in the Management of HCV/HIV Coinfection: Optimizing Treatment...Best Practices in the Management of HCV/HIV Coinfection: Optimizing Treatment...
Best Practices in the Management of HCV/HIV Coinfection: Optimizing Treatment...
Hivlife Info
 
Treatment of HCV Genotype 4
Treatment of HCV Genotype 4Treatment of HCV Genotype 4
Treatment of HCV Genotype 4
Mahmoud Elzalabany
 
Hepatitis c infection, causes, treatment, and prevention
Hepatitis c infection, causes, treatment, and preventionHepatitis c infection, causes, treatment, and prevention
Hepatitis c infection, causes, treatment, and prevention
Nada Sami
 

What's hot (20)

8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid final8. hepatitis c prevention in hr for pwid final
8. hepatitis c prevention in hr for pwid final
 
Revision of treatment protocols for hcv genotype 4 infection 2016
Revision of treatment protocols for hcv genotype 4 infection 2016Revision of treatment protocols for hcv genotype 4 infection 2016
Revision of treatment protocols for hcv genotype 4 infection 2016
 
5. hcv test counselling final
5. hcv test counselling final5. hcv test counselling final
5. hcv test counselling final
 
HCV guidance may_24_2018b
HCV guidance may_24_2018bHCV guidance may_24_2018b
HCV guidance may_24_2018b
 
Hepatitis C presentation by CADTH
Hepatitis C presentation by CADTHHepatitis C presentation by CADTH
Hepatitis C presentation by CADTH
 
Revision of treatment protocols for hcv genotype 4 infection 2016
Revision of treatment protocols for hcv genotype 4 infection 2016Revision of treatment protocols for hcv genotype 4 infection 2016
Revision of treatment protocols for hcv genotype 4 infection 2016
 
02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy02.05.21 | COVID-19 and Pregnancy
02.05.21 | COVID-19 and Pregnancy
 
March 192015talkforresidents final03232015 (1)
March 192015talkforresidents final03232015 (1)March 192015talkforresidents final03232015 (1)
March 192015talkforresidents final03232015 (1)
 
HIV-HCV Co-infection Slide Kit
HIV-HCV Co-infection Slide KitHIV-HCV Co-infection Slide Kit
HIV-HCV Co-infection Slide Kit
 
HIV-HCV coinfection: still special in 2015?
HIV-HCV coinfection: still special in 2015?HIV-HCV coinfection: still special in 2015?
HIV-HCV coinfection: still special in 2015?
 
Who.hcv treatment guidelines 2016
Who.hcv treatment  guidelines 2016Who.hcv treatment  guidelines 2016
Who.hcv treatment guidelines 2016
 
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
10.16.20 | TB or not TB (Burmese Refugee with Brain Mass)
 
HCV Story ---by Mohammed Hussien
HCV Story ---by Mohammed HussienHCV Story ---by Mohammed Hussien
HCV Story ---by Mohammed Hussien
 
HCV management, guidelines 2016
HCV management, guidelines 2016HCV management, guidelines 2016
HCV management, guidelines 2016
 
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
01.29.21 | Cryptococcal Antigen Screening in Resource-Limited Settings
 
Antiretroviral Therapy Update 2014
Antiretroviral Therapy Update 2014Antiretroviral Therapy Update 2014
Antiretroviral Therapy Update 2014
 
Advances in hiv treatment
Advances in hiv treatmentAdvances in hiv treatment
Advances in hiv treatment
 
Best Practices in the Management of HCV/HIV Coinfection: Optimizing Treatment...
Best Practices in the Management of HCV/HIV Coinfection: Optimizing Treatment...Best Practices in the Management of HCV/HIV Coinfection: Optimizing Treatment...
Best Practices in the Management of HCV/HIV Coinfection: Optimizing Treatment...
 
Treatment of HCV Genotype 4
Treatment of HCV Genotype 4Treatment of HCV Genotype 4
Treatment of HCV Genotype 4
 
Hepatitis c infection, causes, treatment, and prevention
Hepatitis c infection, causes, treatment, and preventionHepatitis c infection, causes, treatment, and prevention
Hepatitis c infection, causes, treatment, and prevention
 

Similar to 2. natural history of hepatitis c infection final

Dm &amp; liver
Dm &amp;  liverDm &amp;  liver
Dm &amp; liver
alaa wafa
 
Hodgkin lymphoma case answers
Hodgkin lymphoma case answersHodgkin lymphoma case answers
Hodgkin lymphoma case answers
ABDULLAHALHAJI2
 
Hepatitis C presentation
Hepatitis C presentation Hepatitis C presentation
Hepatitis C presentation
Amr Eldakroury
 
NON-COMMUNICABLE DISEASES WITH REFERENCE TO OBESITY AND CA CERVIX
NON-COMMUNICABLE DISEASES WITH REFERENCE TO OBESITY AND CA CERVIXNON-COMMUNICABLE DISEASES WITH REFERENCE TO OBESITY AND CA CERVIX
NON-COMMUNICABLE DISEASES WITH REFERENCE TO OBESITY AND CA CERVIX
AP Singh
 
Cirrhosis , Diabetes & Infection .. What a triad .?!
Cirrhosis , Diabetes & Infection .. What a triad .?!Cirrhosis , Diabetes & Infection .. What a triad .?!
Cirrhosis , Diabetes & Infection .. What a triad .?!
ElsayedShaaban2
 
liver.pptx
liver.pptxliver.pptx
liver.pptx
MesfinShifara
 
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptx
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptxBurden of liver disease progression in hospitalized patients JOURNAL 2.pptx
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptx
DrHarsh Saxena
 
Leukemia - Teaching practice in nursing medical surgical
Leukemia - Teaching practice in nursing medical surgicalLeukemia - Teaching practice in nursing medical surgical
Leukemia - Teaching practice in nursing medical surgical
swethahaashini
 
NON COMMUNICABLE DISEASE
NON COMMUNICABLE DISEASE NON COMMUNICABLE DISEASE
NON COMMUNICABLE DISEASE
PALAKNARULA7
 
Hepatitis and macrovascular
Hepatitis and macrovascularHepatitis and macrovascular
Hepatitis and macrovascular
manjumanju82
 
The power of personal choices
The power of personal choicesThe power of personal choices
The power of personal choices
EsserHealth
 
hepatits public.pptx
hepatits public.pptxhepatits public.pptx
hepatits public.pptx
AhmdZkri
 
Management of cirrhosis for improving survival
Management of cirrhosis for improving survivalManagement of cirrhosis for improving survival
Management of cirrhosis for improving survival
Mahendra Debbarma
 
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdfNephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
HarmonyOyiko
 
Digestion System's Diseases
Digestion System's DiseasesDigestion System's Diseases
Digestion System's Diseases
melyoddl
 
AUTOIMMUNE HEPATITIS.pptx
AUTOIMMUNE HEPATITIS.pptxAUTOIMMUNE HEPATITIS.pptx
AUTOIMMUNE HEPATITIS.pptx
Kemi Adaramola
 
Vasudha main
Vasudha mainVasudha main
Vasudha main
Vasudha Krishna
 
Cancer and Diabetes
Cancer and DiabetesCancer and Diabetes
Cancer and Diabetes
SIHAS
 
Overview of COVID-19
Overview of COVID-19Overview of COVID-19
Overview of COVID-19
Adaiah
 
Crohn’s disease
Crohn’s diseaseCrohn’s disease
Crohn’s disease
yellowman74
 

Similar to 2. natural history of hepatitis c infection final (20)

Dm &amp; liver
Dm &amp;  liverDm &amp;  liver
Dm &amp; liver
 
Hodgkin lymphoma case answers
Hodgkin lymphoma case answersHodgkin lymphoma case answers
Hodgkin lymphoma case answers
 
Hepatitis C presentation
Hepatitis C presentation Hepatitis C presentation
Hepatitis C presentation
 
NON-COMMUNICABLE DISEASES WITH REFERENCE TO OBESITY AND CA CERVIX
NON-COMMUNICABLE DISEASES WITH REFERENCE TO OBESITY AND CA CERVIXNON-COMMUNICABLE DISEASES WITH REFERENCE TO OBESITY AND CA CERVIX
NON-COMMUNICABLE DISEASES WITH REFERENCE TO OBESITY AND CA CERVIX
 
Cirrhosis , Diabetes & Infection .. What a triad .?!
Cirrhosis , Diabetes & Infection .. What a triad .?!Cirrhosis , Diabetes & Infection .. What a triad .?!
Cirrhosis , Diabetes & Infection .. What a triad .?!
 
liver.pptx
liver.pptxliver.pptx
liver.pptx
 
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptx
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptxBurden of liver disease progression in hospitalized patients JOURNAL 2.pptx
Burden of liver disease progression in hospitalized patients JOURNAL 2.pptx
 
Leukemia - Teaching practice in nursing medical surgical
Leukemia - Teaching practice in nursing medical surgicalLeukemia - Teaching practice in nursing medical surgical
Leukemia - Teaching practice in nursing medical surgical
 
NON COMMUNICABLE DISEASE
NON COMMUNICABLE DISEASE NON COMMUNICABLE DISEASE
NON COMMUNICABLE DISEASE
 
Hepatitis and macrovascular
Hepatitis and macrovascularHepatitis and macrovascular
Hepatitis and macrovascular
 
The power of personal choices
The power of personal choicesThe power of personal choices
The power of personal choices
 
hepatits public.pptx
hepatits public.pptxhepatits public.pptx
hepatits public.pptx
 
Management of cirrhosis for improving survival
Management of cirrhosis for improving survivalManagement of cirrhosis for improving survival
Management of cirrhosis for improving survival
 
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdfNephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
Nephrotic-Syndrome-in-Children-Dr.-Bashir-Admani.pdf
 
Digestion System's Diseases
Digestion System's DiseasesDigestion System's Diseases
Digestion System's Diseases
 
AUTOIMMUNE HEPATITIS.pptx
AUTOIMMUNE HEPATITIS.pptxAUTOIMMUNE HEPATITIS.pptx
AUTOIMMUNE HEPATITIS.pptx
 
Vasudha main
Vasudha mainVasudha main
Vasudha main
 
Cancer and Diabetes
Cancer and DiabetesCancer and Diabetes
Cancer and Diabetes
 
Overview of COVID-19
Overview of COVID-19Overview of COVID-19
Overview of COVID-19
 
Crohn’s disease
Crohn’s diseaseCrohn’s disease
Crohn’s disease
 

Recently uploaded

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
AksshayaRajanbabu
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
arahmanzai5
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
bkling
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Swastik Ayurveda
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 

Recently uploaded (20)

8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Abortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentationAbortion PG Seminar Power point presentation
Abortion PG Seminar Power point presentation
 
Diabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatmentDiabetic nephropathy diagnosis treatment
Diabetic nephropathy diagnosis treatment
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
Part II - Body Grief: Losing parts of ourselves and our identity before, duri...
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptxVestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
Vestibulocochlear Nerve by Dr. Rabia Inam Gandapore.pptx
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 

2. natural history of hepatitis c infection final

  • 1. Dr. Jules Alla Kouadio (Médecins du Monde) Training “Hepatitis C and HR for PWUD”, 20th -24th Sept. 2016, Nairobi, Kenya Section 2: Natural History of Hepatitis C
  • 2. Learning objective of the session: Describing HCV acute infection Describing the different stages of liver fibrosis Outlining factors affecting progress/accelerating of liver fibrosis
  • 3. » Acute infection (within 6 months of initial infection) – Most patients are asymptomatic – Only 10% have symptomatic illness. » Symptoms of acute infection usually appears within 4 to 12 weeks of initial infection and may persists for 2 to 12 weeks. When a patient is recently infected with hepatitis C virus
  • 4. Symptoms of Acute Infection
  • 5. » Hepatitis C causes serious problems in some patients – Fibrosis – Cirrhosis – Advanced liver disease – Hepatocellular carcinoma (liver cancer) Why should you be concerned about hepatitis C?
  • 6. » The beginning of scarring » Caused by infection, inflammation, or injury » Can prevent the liver from working well » Can lead to permanent scarring (cirrhosis) Fibrosis
  • 7. » Pronounced “sir-o-sis” » Means “scarring of the liver” » At risk for liver failure and liver cancer » Requires close medical follow-up Cirrhosis Healthy Liver Liver with Cirrhosis
  • 8. » Fatigue » Difficulty thinking clearly or concentrating » Yellow jaundice » Swelling » Fluid in the abdomen » Gastrointestinal bleeding » Poor blood clotting Advanced Liver Disease
  • 9. » Most common type of liver cancer » Chronic hepatitis C increases the risk » Treated with surgery, medications or liver transplant Hepatocellular Carcinoma
  • 10. Natural History of Hepatitis C 20 years progression rate accelerated with HIV, HBV, Obesity, Diabetes, alcohol and cannabis May also have Extra Hepatic manifestations
  • 11. Natural History of Hepatitis C
  • 12. Stage of Liver Fibrosis
  • 13. Extra Hepatic Manifestations Associated with HCV 11 NIH.NIH. NIH Consens State Sci StatementsNIH Consens State Sci Statements. 2002;19(3):1-46.. 2002;19(3):1-46. 22 Sene D et al.Sene D et al. Metab Brain DisMetab Brain Dis. 2004;19(3-4):357-381.. 2004;19(3-4):357-381. HematologicHematologic • Mixed cryoglobulinemiaMixed cryoglobulinemia11 • Aplastic anemiaAplastic anemia22 • ThrombocytopeniaThrombocytopenia22 • Non-Hodgkin's b-cell lymphomaNon-Hodgkin's b-cell lymphoma22 DermatologicDermatologic • Porphyria cutanea tardaPorphyria cutanea tarda11 • Lichen planusLichen planus22 • Cutaneous necrotizingCutaneous necrotizing • vasculitis2vasculitis2 RenalRenal • GlomerulonephritisGlomerulonephritis11 • Nephrotic syndromeNephrotic syndrome22 EndocrineEndocrine • HypothyroidismHypothyroidism22 • Diabetes mellitusDiabetes mellitus22 OcularOcular • Corneal ulcerCorneal ulcer22 • UveitisUveitis22 VascularVascular • Necrotizing vasculitisNecrotizing vasculitis22 • Polyarteritis nodosaPolyarteritis nodosa22 NeuromuscularNeuromuscular22 • Weakness/myalgiaWeakness/myalgia • Peripheral neuropathyPeripheral neuropathy • Arthritis/arthralgiaArthritis/arthralgia Autoimmune PhenomenaAutoimmune Phenomena22 • CREST syndromeCREST syndrome NeuropsychiatricNeuropsychiatric • DepressionDepression11
  • 14. » Alcohol consumption – Alcohol significantly speeds up the rate of fibrosis » Age and duration of infection – People over 40 are progressively more susceptible to faster rates of fibrosis. » Gender – Men are more likely to have faster progression to cirrhosis than women » Co-infection with HIV and Hepatitis B – HIV-HCV co-infection causes progression of liver damage » Fatty liver – Fat accumulates in the liver if it is unable to metabolize it properly due to liver damage or excessive intake of fat through diet » And other factors such as Drugs ,Metabolic syndrome, Virological factors and coffee Factors affecting disease progression
  • 15. 1. Age/duration of infection 2. Co-infection with HIV also accelerated the progress of liver disease – clearance of HCV is associated with strong and persistent HCV- specific cytotoxic T-lymphocyte and CD4 lymphocyte responses 1. Co-infection with HBV increase the risk of liver fibrosis and HCC Factors affecting disease progression
  • 16. Alcohol consumption and chance of getting cirrhosis Drinker Without Hepatitis C Drinker With Hepatitis C Hepatitis C Non-Drinker Chance Of Getting Cirrhosis Non-Drinker
  • 17. What is Excessive alcohol intake? » A standard drink of alcohol is defined as 10 grams of alcohol » Excessive alcohol intake defined as >40 grams/day for Women and >60 grams/day for Men
  • 18. Alcohol intake recommended by WHO » An Alcohol intake assessment is recommended for all person with HCV infection. » Behaviour alcohol reduction intervention is recommended for a person with moderate to high alcohol intake.
  • 19. Metabolic Syndrome » Multiplex risk factors due to insulin resistance together with abnormal adipose deposition (Obesity+Diabetes) » It is also a risk factor for coronary heart disease and fatty liver
  • 20. What can we advice if a patient has metabolic syndrome ? » Life style modification – Mainly diet and exercise – To maintain the body weight within normal range BMI >18.5 and <25 » Pharmacological therapy (for Hypertension, Diabetes, hyperlipidaemia) if necessary
  • 21. Marijuana (Bhang) » Marijuana use is associated with accelerated liver fibrosis due to a strong link between heavy use of marijuana and steatosis. » There is limited data available on the correlation between Marijuana and Hep C. Therefore, WHO has no recommendation on Marijuana used in Hep C patient in April 2016 revised guideline.
  • 22. How can identify Marijuana be used » Assessment of drug use » Suggest the patient to reduce the use of Marijuana as much as possible
  • 23. Herbs and over the counter drugs » Chronic use of acetaminophen (paracetamol , Tylenol® and others) also increase the risk of liver damage. » Ibuprofen and other anti-inflammatory medications (Motrin® , Advil® , Aleve® , and others) » Herbal medicines are also widely used in Kenya and most of the herbal medicines have no clear ingredients or effects. » Iron supplements not recommended – They may increase the rate of liver scarring – Milk thistle is safe, BUT not shown to improve liver disease Talk with your medical care provider before starting any new medication or supplement
  • 24. What kinds of advice should be given to the patients ? » Not to take over-the-counter drugs » Take medicines only when necessary under the prescription of medical doctor » To avoid using herbs or traditional medicines » Need to be vaccinated against Hep B
  • 25. Virological Factor Some studies show that Genotype 3 is associated with higher prevalence of steatosis which in turn accelerated liver fibrosis.
  • 26. Protection factor: Coffee » Some studies show that regular taking of coffee (3 cups a day) may slow down the rate of progression of liver disease in Hep C patients.
  • 27. Exercice 1 : Quizz » What % of HCV infected people develops chronic HCV infection? » What % of HCV infected people develops serious liver disease? » How long might this take? » What factors might stop, slow down or increase the risk of disease progression?
  • 28. Exercise 2 1. HIV/HCV coinfection 2. HBV/HCV coinfection 3. Use 3 big cup of strong alcohol per day 4. Taking regularly paracetamol as pain killer 5. Smoking Marijuana 6. Being overweight 7. Being 55 years old 8. Injecting heroin with friends occasionally 1/ Print each elements below on a single papersheet, and distribute one sheet to every participant 9. Getting tested for HCV 10. Being vaccinated againt HBV 11. Using my own equipment whenever using drugs 12. Taking methadone 13. Taking a lot of herbal treatment 14. HCV treatment 15. Reducing alcohol consumption 16. Good follow up on HIV treatment
  • 29. 2/ Identify in the room 3 corners: 1) factors accelerating liver disease 2) factors protective of liver disease 3) factors having no effect on liver disease 3/ Ask participants to stand in the corner corresponding to the information on his· her papershette and explain to the group his· her choice
  • 30. This presentation was produced with the financial support of the French development agency (AFD – Agence Franç aise de développement). The ideas and opinions it contains are those of Médecins du Monde and do not necessarily represent those of AFD.